CWA Asset Management Group, LLC

Position in NVS — Novartis AG

CIK 1667134 NAPLES, FL

Position in NVS

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$4,557,887

+$426,916 QoQ

Shares Held

29,083

+7.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#274

of 1,603 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CWA Asset Management Group, LLC holds $104,319,210 across 14 Drug Manufacturers - General names. NVS ranks #8 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	97,695	$24,811,599
2	ABBV	AbbVie Inc.	86,259	$21,706,214
3	BMY	Bristol Myers Squibb Co	179,351	$10,334,204
4	LLY	ELI LILLY & Co	7,425	$8,905,768
5	BIIB	Biogen Inc.	38,127	$8,237,719
6	GILD	Gilead Sciences, Inc.	63,399	$8,009,829
7	MRK	Merck & Co., Inc.	38,429	$4,938,126
8	NVS	Novartis AG This page	29,083	$4,557,887

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,557,887	29,083	+7.5%	Shares	Sole	2026-07-14
2026-03-31	$4,130,971	27,044	-0.6%	Shares	Sole	2026-04-20
2025-12-31	$3,751,856	27,213	+151.9%	Shares	Sole	2026-01-07
2025-09-30	$1,385,504	10,804	+0.5%	Shares	Sole	2025-10-22
2025-06-30	$1,300,615	10,748	-71.4%	Shares	Sole	2025-07-17
2025-03-31	$4,196,776	37,646	+22.1%	Shares	Sole	2025-04-21
2024-12-31	$3,001,040	30,840	+20.1%	Shares	Sole	2025-01-06
2024-09-30	$2,953,253	25,676	+38.9%	Shares	Sole	2024-11-01
2024-03-31	$1,788,054	18,485	+130.3%	Shares	Sole	2024-05-13
2023-12-31	$810,587	8,028	-68.9%	Shares	Sole	2024-02-13
2020-12-31	$2,439,976	25,839	+3.6%	Shares	Sole	2021-02-23
2020-09-30	$2,169,565	24,949	+13.3%	Shares	Sole	2020-11-13
2020-06-30	$1,922,877	22,016	-5.3%	Shares	Sole	2020-08-13
2020-03-31	$1,916,797	23,248	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.